Senti Biosciences, Inc. (SNTI) Balance Sheet
SNTI balance sheet, 2025
December 31, 2025 · U.S. dollars$51.2M assets = $45.6M liabilities + $5.6M equity
Both columns are drawn to the same scale: what SNTI owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SNTI financial health
Descriptive bands, not a rating. Fiscal 2025.
SNTI balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $35.8M2019 | $51.2M2025 | +6.1%/yr | |
| Total liabilities | $17.9M2019 | $45.6M2025 | +16.9%/yr | |
| Shareholders’ equity | $18.0M2019 | $5.6M2025 | −17.7%/yr | |
| Cash & short-term investments | $17.8M2019 | $16.4M2025 | −1.4%/yr | |
| Total debt | $14.0M2020 | $28.9M2025 | +15.5%/yr | |
| Net cash (debt) | $16.5M2020 | −$12.5M2025 | −$29.0M | |
| Working capital | $14.5M2019 | $9.3M2025 | −$5.2M | |
| Current ratio | 4.362019 | 1.672025 | −2.69 | |
| Debt / equity | 0.382021 | 5.172025 | +4.79 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SNTI assets
SNTI liabilities and equity
SNTI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SNTI balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $16.4M | $48.3M | $35.9M | $98.6M | $56.0M | $30.5M | $17.8M |
| Cash & equivalents | $16.4M | $48.3M | $35.9M | $57.6M | $56.0M | $30.5M | $5.3M |
| Short-term investments | — | — | $0 | $40.9M | $1.2M | $25,000 | $12.5M |
| Receivables | $1.6M | $1.8M | $17.7M | $626,000 | $483,000 | $317,000 | $78,000 |
| Inventory | $0 | $335,000 | $0 | $3.3M | $2.6M | $25,000 | $0 |
| Other current assets | $5.3M | $8.5M | $17.6M | $101,000 | $0 | $830,000 | $853,000 |
| Total current assets | $23.3M | $59.0M | $71.2M | $102.6M | $58.7M | $31.7M | $18.8M |
| Property, plant & equipment (net) | $24.4M | $35.2M | $41.6M | $74.6M | $33.1M | $16.1M | $16.6M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $3.5M | $3.6M | $6.7M | $3.7M | $4.9M | $497,000 | $497,000 |
| Total assets | $51.2M | $97.8M | $119.5M | $180.8M | $96.7M | $48.3M | $35.8M |
| Liabilities | |||||||
| Accounts payable | $2.9M | $1.5M | $1.2M | $2.3M | $5.2M | $914,000 | $1.2M |
| Short-term debt | $5.3M | $4.8M | $4.1M | $2.0M | $1.7M | $1.5M | — |
| Deferred revenue | $347,000 | $660,000 | $989,000 | $799,000 | $1.7M | $2.0M | — |
| Total current liabilities | $14.0M | $13.1M | $12.7M | $18.1M | $14.5M | $4.9M | $4.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $28.9M | $33.6M | $37.7M | $37.1M | $22.7M | $14.0M | — |
| Other long-term liabilities | $31.7M | $59.0M | $39.9M | $35.5M | $21.8M | $102.2M | $13.6M |
| Total liabilities | $45.6M | $72.2M | $52.6M | $53.5M | $36.3M | $107.1M | $17.9M |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $3,000 | $1,000 | $5,000 | $4,000 | $1,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$358.6M | −$297.1M | −$244.3M | −$173.3M | −$115.1M | −$59.8M | −$39.9M |
| Accumulated other comprehensive income | — | — | −$119.5M | $1,000 | −$171.8M | −$89.7M | — |
| Total shareholders' equity | $5.6M | $25.6M | $66.9M | $127.3M | $60.4M | −$58.7M | $18.0M |
| Key figures | |||||||
| Total debt | $28.9M | $33.6M | $37.7M | $37.1M | $22.7M | $14.0M | — |
| Net cash (debt) | −$12.5M | $14.6M | −$1.7M | $61.5M | $33.3M | $16.5M | — |
| Working capital | $9.3M | $45.8M | $58.5M | $84.5M | $44.2M | $26.8M | $14.5M |
| Tangible book value | $5.6M | $25.6M | $66.9M | $127.3M | $60.4M | −$58.7M | $18.0M |
| Current ratio | 1.67 | 4.49 | 5.62 | 5.68 | 4.04 | 6.52 | 4.36 |
| Quick ratio | 1.29 | 3.81 | 4.23 | 5.49 | 3.89 | 6.34 | 4.16 |
| Debt / equity | 5.17 | 1.31 | 0.56 | 0.29 | 0.38 | — | — |
| Equity / assets | 10.9% | 26.2% | 56.0% | 70.4% | 62.4% | −121.4% | 50.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $6.5M | $8.9M | $16.4M | $12.2M | $21.6M | $33.8M | $48.3M | $10.5M | $15.9M | $23.7M | $35.9M | $39.4M |
| Cash & equivalents | $6.5M | $8.9M | $16.4M | $12.2M | $21.6M | $33.8M | $48.3M | $10.5M | $15.9M | $23.7M | $35.9M | $39.4M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | $0 | $652,000 |
| Receivables | $557,000 | $765,000 | $1.6M | $1.7M | $3.7M | $2.2M | $1.8M | $1.2M | $18.7M | $17.9M | $17.7M | $18.6M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $335,000 | $0 | $0 | $0 | $0 | −$39.6M |
| Other current assets | $6.0M | $5.1M | $5.3M | $4.2M | $7.3M | $9.2M | $8.5M | $5.7M | $9.8M | $14.0M | $17.6M | $60.5M |
| Total current assets | $13.0M | $14.8M | $23.3M | $18.2M | $32.5M | $45.2M | $59.0M | $17.4M | $44.3M | $55.7M | $71.2M | $79.0M |
| Property, plant & equipment (net) | $18.7M | $19.9M | $24.4M | $31.0M | $32.4M | $33.9M | $35.2M | $36.7M | $38.6M | $40.2M | $41.6M | $43.5M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.4M | $3.5M | $3.5M | $3.6M | $3.6M | $3.6M | $3.6M | $3.6M | $4.0M | $6.4M | $6.7M | $9.3M |
| Total assets | $33.1M | $38.2M | $51.2M | $52.7M | $68.5M | $82.8M | $97.8M | $57.7M | $86.9M | $102.2M | $119.5M | $131.8M |
| Liabilities | ||||||||||||
| Accounts payable | $2.2M | $1.1M | $2.9M | $1.8M | $1.0M | $1.6M | $1.5M | $793,000 | $1.2M | $1.6M | $1.2M | $2.0M |
| Short-term debt | $7.5M | $5.9M | $5.3M | $5.2M | $5.0M | $4.8M | $4.8M | $4.6M | $4.4M | $4.3M | $4.1M | $2.7M |
| Deferred revenue | $1.9M | $2.3M | $347,000 | — | $360,000 | $513,000 | $660,000 | $639,000 | $798,000 | $862,000 | $989,000 | $1.0M |
| Total current liabilities | $15.8M | $14.3M | $14.0M | $12.0M | $10.0M | $10.7M | $13.1M | $9.1M | $9.1M | $9.6M | $12.7M | $10.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $16.2M | $19.1M | $28.9M | $30.1M | $31.3M | $32.4M | $33.6M | $34.7M | $35.7M | $36.7M | $37.7M | $37.3M |
| Other long-term liabilities | $20.7M | $21.4M | $31.7M | $32.5M | $33.9M | $34.2M | $59.0M | $32.7M | $33.7M | $36.5M | $39.9M | $38.7M |
| Total liabilities | $36.5M | $35.7M | $45.6M | $44.6M | $43.9M | $44.9M | $72.2M | $41.7M | $42.8M | $46.1M | $52.6M | $48.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $1,000 | $1,000 | $1,000 | $5,000 | $5,000 | $4,000 |
| Retained earnings (deficit) | −$375.5M | −$362.8M | −$358.6M | −$344.1M | −$326.0M | −$311.2M | −$297.1M | −$296.5M | −$267.7M | −$256.5M | −$244.3M | −$225.6M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | −$119.5M | −$119.5M | — |
| Total shareholders' equity | −$3.4M | $2.6M | $5.6M | $8.1M | $24.7M | $37.9M | $25.6M | $16.0M | $44.1M | $56.1M | $66.9M | $82.9M |
| Key figures | ||||||||||||
| Total debt | $20.2M | $19.1M | $28.9M | $30.1M | $31.3M | $32.4M | $33.6M | $34.7M | $35.7M | $36.7M | $37.7M | $37.3M |
| Net cash (debt) | −$13.8M | −$10.2M | −$12.5M | −$17.9M | −$9.7M | $1.4M | $14.6M | −$24.2M | −$19.9M | −$13.0M | −$1.7M | $2.1M |
| Working capital | −$2.8M | $522,000 | $9.3M | $6.1M | $22.5M | $34.5M | $45.8M | $8.3M | $35.3M | $46.1M | $58.5M | $68.9M |
| Tangible book value | −$3.4M | $2.6M | $5.6M | $8.1M | $24.7M | $37.9M | $25.6M | $16.0M | $44.1M | $56.1M | $66.9M | $82.9M |
| Book value per share | −$0.11 | $0.08 | $0.25 | $0.31 | $0.95 | $3.78 | — | — | — | — | — | — |
| Shares outstanding | 31.1M | 31.0M | 22.5M | 26.2M | 26.1M | 10.0M | — | — | — | — | — | — |
| Current ratio | 0.83 | 1.04 | 1.67 | 1.51 | 3.26 | 4.22 | 4.49 | 1.92 | 4.89 | 5.79 | 5.62 | 7.81 |
| Quick ratio | 0.45 | 0.68 | 1.29 | 1.16 | 2.53 | 3.36 | 3.81 | 1.29 | 3.81 | 4.33 | 4.23 | 5.74 |
| Debt / equity | — | 7.46 | 5.17 | 3.71 | 1.27 | 0.86 | 1.31 | 2.17 | 0.81 | 0.65 | 0.56 | 0.45 |
| Equity / assets | −10.3% | 6.7% | 10.9% | 15.4% | 36.0% | 45.7% | 26.2% | 27.7% | 50.8% | 54.9% | 56.0% | 62.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2026); data from EODHD.
SNTI financial position
At the end of fiscal 2025 (December 31, 2025), Senti Biosciences had total assets of $51.2 million (down 47.6% from a year earlier), total liabilities of $45.6 million and shareholders' equity of $5.6 million. It held $16.4 million in cash and short-term investments against $28.9 million of debt, net debt of $12.5 million. Its current ratio was 1.67. In the latest quarter (ended June 30, 2026) total assets were $33.1 million and equity -$3.4 million.
Related: SNTI income statement, SNTI cash flow statement, SNTI key metrics. See the SNTI stock overview for the latest quote and news.
SNTI balance sheet FAQ
What are Senti Biosciences's total assets?
Senti Biosciences reported total assets of $51.2 million at the end of fiscal 2025 (December 31, 2025), compared with $97.8 million a year earlier.
How much debt does Senti Biosciences have?
Senti Biosciences had $28.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 5.17.
How much cash does Senti Biosciences have?
Senti Biosciences held $16.4 million in cash and short-term investments at the end of fiscal 2025; with $28.9 million of debt that is net debt of $12.5 million.
What is Senti Biosciences's book value?
Senti Biosciences's shareholders' equity (book value) was $5.6 million at the end of fiscal 2025.
What is Senti Biosciences's current ratio?
Senti Biosciences had current assets of $23.3 million and current liabilities of $14.0 million, a current ratio of 1.67 (it can cover its short-term obligations).